Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test
(Alliance News) - Ixico PLC on Tuesday hailed regulatory approval for a new Alzheimer's test, which it was contracted to analyse during clinical trials. Read More
Price | 11.50p on 19-06-2025 | at 18:25:09
---|---|
Change | -0.25p -2.13% |
Buy | 12.00p |
Sell | 11.00p |
Buy / Sell IXI Shares |
Last Trade: | Buy 200.00 at 12.00p |
Day's Volume: | 127,519 |
Last Close: | 11.50p |
Open: | 11.75p |
ISIN: | GB00BFXR4C20 |
Day's Range | 11.50p - 11.75p |
52wk Range: | 6.60p - 13.50p |
Market Capitalisation: | £11m |
VWAP: | 11.63726p |
Shares in Issue: | 93m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 200 | 12.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Buy* | 20 | 12.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Buy* | 25 | 12.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Sell* | 10 | 11.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Sell* | 550 | 11.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Buy* | 691 | 12.00p | SI Trade |
15:51:04 - 19-Jun-25 |
Sell* | 25,000 | 11.55p | Ordinary |
14:44:32 - 19-Jun-25 |
Sell* | 50,000 | 11.505p | Ordinary |
14:31:34 - 19-Jun-25 |
Buy* | 42,107 | 11.865p | Ordinary |
11:22:28 - 19-Jun-25 |
Sell* | 8,916 | 11.55p | Ordinary |
10:59:03 - 19-Jun-25 |
Ixico (IXI) Regulatory News |
||
Date | Source | Headline |
---|---|---|
13th Jun 2025 8:03 am | RNS | Share option awards and PDMR Dealing |
10th Jun 2025 7:00 am | RNS | FDA Clearance of Alzheimer's Diagnostic Biomarker |
20th May 2025 6:00 pm | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | Half-year Report |
8th May 2025 11:30 am | RNS | Holding(s) in Company |
6th May 2025 7:00 am | RNS | Notice of Interim Results & Investor Presentation |
16th Apr 2025 7:00 am | RNS | Trading Update |
27th Feb 2025 7:00 am | RNS | Contract Win |
12th Feb 2025 7:00 am | RNS | Further Validation of IXICO’s AI Imaging Platform |
7th Feb 2025 3:00 pm | RNS | Issue of share options and PDMR dealing |